Drugs / SODIUM CAPRYLATE
SODIUM CAPRYLATE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01244503 | Feb 2011 → May 2012 | NAFLD1, metabolic syndrome X | Virginia Commonwealth University | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SODIUM CAPRYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL557076 ↗ |
| Known as | Octanoate | “100 mg of 13-C labeled sodium octanoate (Octanoate for short)” NCT01244503 ↗ |
| Known as | Octanoic acid, sodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL557076 ↗ |
| Known as | sodium octanoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01244503 ↗ |
| Modality | Small molecule | — CHEMBL557076 ↗ |
| Route | Oral | “dissolved in 1 cup of tap water and administered to subject after baseline breath collection is completed” NCT01244503 ↗ |